Average Co-Inventor Count = 5.38
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Opko Ireland Global Holdings, Limited (8 from 24 patents)
2. Opko Renal, LLC (6 from 17 patents)
3. Eirgen Pharma Ltd. (2 from 16 patents)
4. Cytochroma Inc. (2 from 16 patents)
5. Proventiv Therapeutics, LLC (2 from 5 patents)
6. Opko IP Holdings Ii, Inc. (1 from 2 patents)
13 patents:
1. 11253528 - Stabilized modified release Vitamin D formulation and method of administering same
2. 11154509 - Methods for controlled release oral dosage of a vitamin D compound
3. 10357502 - Stabilized modified release vitamin D formulation and method of administering same
4. 10350224 - Stabilized modified release vitamin D formulation and method of administering same
5. 10300078 - Stabilized modified release vitamin D formulation and method of administering same
6. 9925147 - Method for treating secondary hyperparathyroidism in CKD
7. 9918940 - Methods for controlled release oral dosage of a vitamin D compound
8. 9861644 - Stabilized modified release vitamin D formulation and method of administering same
9. 9498486 - Method for controlled release oral dosage of a vitamin D compound
10. 9408858 - Method for treating secondary hyperparathyroidism in CKD
11. 8778373 - Methods for controlled release oral dosage of a vitamin D compound
12. 8361488 - Methods and compositions for controlled release oral dosage of a vitamin D compound
13. 8207149 - Method for treating secondary hyperparathyroidism in CKD